Craft

Jeil Pharmaceutical

Stock Price

₩14.1 K

2024-10-29

Market Capitalization

₩205.5 B

2024-10-29

Revenue

₩704.5 B

FY, 2024

Jeil Pharmaceutical Summary

Company Summary

Overview
Jeil Pharmaceutical (제일약품) is a company that develops and manufactures pharmaceutical products. It specializes in pharmacology and toxicology, organic synthesis, formulation, and analysis of new drug ingredients, modified drugs, and generic drugs. The company provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine.
Type
Public
Status
Active
Founded
1959
HQ
KR | view all locations
Website
https://www.jeilpharm.co.kr/jeilpharm/intro.asp
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Seoul HQ

    Korea (Republic of)

    343 Sapyeong-daero, Seocho-gu

Jeil Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2025)
₩134.8B
Gross profit (Q3, 2025)
₩57.8B
Net income (Q3, 2025)
₩15.9B
Cash (Q3, 2025)
₩51.8B
EBIT (Q3, 2025)
₩17.6B
Enterprise value
$246.6B

Footer menu